Omvoh (mirikizumab-mrkz) coverage for UC and CD
Customize your policy alerts
Sign up for sierra health and life Policy 2026D0129F alerts
Get alerted when Policy 2026D0129F changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical and pharmacy benefit coverage and prior authorization requirements for Omvoh (mirikizumab-mrkz) for treatment of moderately to severely active ulcerative colitis and Crohn's disease for UnitedHealthcare Commercial and Individual Exchange plans.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.